These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 18157581)

  • 1. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
    DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
    J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer screening mode preferences among US veterans.
    Powell AA; Burgess DJ; Vernon SW; Griffin JM; Grill JP; Noorbaloochi S; Partin MR
    Prev Med; 2009 Nov; 49(5):442-8. PubMed ID: 19747502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient preferences for colorectal cancer screening: how does stool DNA testing fare?
    Schroy PC; Lal S; Glick JT; Robinson PA; Zamor P; Heeren TC
    Am J Manag Care; 2007 Jul; 13(7):393-400. PubMed ID: 17620034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening: physician attitudes and practices.
    Taylor ML; Anderson R
    WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.
    Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I
    BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
    Schroy PC; Heeren TC
    Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored navigation in colorectal cancer screening.
    Myers RE; Hyslop T; Sifri R; Bittner-Fagan H; Katurakes NC; Cocroft J; Dicarlo M; Wolf T
    Med Care; 2008 Sep; 46(9 Suppl 1):S123-31. PubMed ID: 18725824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
    Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
    Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in screening for colorectal cancer in older Americans: results from a national survey.
    Chen X; White MC; Peipins LA; Seeff LC
    J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal occult blood testing instructions and impact on patient adherence.
    Bapuji SB; Lobchuk MM; McClement SE; Sisler JJ; Katz A; Martens P
    Cancer Epidemiol; 2012 Aug; 36(4):e258-64. PubMed ID: 22504053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening attitudes and practices preferences for decision making.
    Messina CR; Lane DS; Grimson R
    Am J Prev Med; 2005 Jun; 28(5):439-46. PubMed ID: 15894147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
    Tong S; Hughes K; Oldenburg B; Del Mar C
    Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.
    Stokamer CL; Tenner CT; Chaudhuri J; Vazquez E; Bini EJ
    J Gen Intern Med; 2005 Mar; 20(3):278-82. PubMed ID: 15836533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.
    Seeff LC; Shapiro JA; Nadel MR
    J Fam Pract; 2002 Sep; 51(9):761-6. PubMed ID: 12366896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care patients' understanding of colorectal cancer screening.
    Greisinger A; Hawley ST; Bettencourt JL; Perz CA; Vernon SW
    Cancer Detect Prev; 2006; 30(1):67-74. PubMed ID: 16458449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.
    Stock C; Ihle P; Schubert I; Brenner H
    Endoscopy; 2011 Sep; 43(9):771-81. PubMed ID: 21830189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of fecal occult blood test (FOBT) completion among low-income adults.
    Greiner KA; James AS; Born W; Hall S; Engelman KK; Okuyemi KS; Ahluwalia JS
    Prev Med; 2005 Aug; 41(2):676-84. PubMed ID: 15917068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
    Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.